1SCHIEVE L A, MEIKLE 5 F, FERRE C, et al. Low and ve- ry low birth weight in infants conceived with use of assisted re- productive technology[J]. N Engl J Med, 2002,346(10) :731- 737.
2JACKSON R A, GIBSON K A, WU Y W, et al. Perinatal outcomes in singletons following in vitro fertilization: a meta- analysis[J]. Obstet Gynecol, 2005,103(3) : 551-563.
3EL-CHAAR D, YANG Q, GAO J, et al. Risk of birth defects increased in pregnancies conceived by assisted human repro- duction[J]. Fertil Steril, 2009,92(5) ,1557-1561.
4STROMBERG B, DAHLQUIST G, ERICSON A, et al. Neu- rological sequelae in children horn after in-vitro fertilisation: a population-based study[J]. Lancet, 2002,359(935) :461-465.
5KOIVUROVA S, HARTIKAINEN A L, GISSLER M, et al. Neonatal outcome and congenital malformations in children born after in-vitro fertilization[J]. Hum Reprod, 2002,17 (5) : 1391-1398.
6BONDUELLE M, WENNERHOLM U B, LOFT A, et al. A multi centre cohort study of the physical health of 5-year-old children conceived after intracytoplasmic sperm injection, in vitro fertilization and natural conception l J]. Hum Reprod, 2005,20(2):413 419.
7BASATEMUR E, SI-IEVLIN M, gUTCLIFFE A. Growth of children conceived by IVF and ICSI up to 12 years of age[J]. Reprod Biomed Online, 2010,20(1) : 144-149.
8COLPIN H, BOSSAERT G. Adolescents conceived by IVF: parenting and psychosocial adjustment [J]. Hum Reprod, 2008,23(12) :2724-Z730.
9WAGENAAR K, CEELEN M, VAN WEISSENBRUCH M M, et al. School functioning in g-to 18-year-old children born after in vitro fertilization[J]. Eur J Pediatr, 2008,167 (11) : 1289-1295.
10LESLIE G I, GIBSON F L, MCMAHON C, et al. Children conceived using ICSI do not have an increased risk of delayed mental development at 5 years of age[J]. Hum Reprod, 2003, 18 (10) : 2067-2072.
二级参考文献28
1SOLOMON C G. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks[J]. Endocrinol Metab Clin North Am, 1999,28(2) : 247-263.
2BIRDSALL M A, FARQUHAR C M. Polycystic ovaries in pre and post-menopausal women[J]. Clin Endocrinol (Oxf), 1996,44(3):269-276.
3GALVANI V, PRETNAR H, RUPREHT R R, et al. Solu hie tumor necrosis factor receptor Ⅰ (sTNFR Ⅰ ) as a prog nostic factor in melanoma patients in Slovene population[J]. Pflugers Arch, 2000,440(5 Suppl) :R61-63.
4ROLDAN B, SAN MILLAN J L,ESCOBAR-MORREALE H F. Genetic basis of metabolic abnormalities in polycystic ovary syndrome: implications for therapy[J]. Am J Pharrnaco genomics, 2004,4(2) : 93-107.
5BURKS D J, FONT DE MORA J, SCHUBERT M, et al. IRS-2 pathways integrate female reproduction and energy homeostasis[J]. Nature, 2000,407(6802):377-382.
6MAGOFFIN D A, KURTZ K M, ERICKSON G F. Insulinlike growth factor-1 selectively stimulates 9 cholesterol sidechain cleavage expressions in ovarian theea-interstitial cells [J]. Mol Endocrinol, 1990,4(3) :489-496.
7TEEDE H J, HUTCHISON S, ZOUNGAS S, et al. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS[J]. Endocrine, 2006, 30:45-53.
8SPACZYNSKI R Z, ARICI A, DULEBA A J. Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells[J]. Biol Reprod, 1999,61(4):993-998.
9TIEPOLO L,ZUFFARDI O.Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm[J].Hum Genet,1976,34(2):119-124.
10REIJO R,ALAGAPPAN R K,PATRIZIO P,et al.Severe oligozoospermia resulting from deletions of azoospermia factor on Y chromosome[J].Lancet,1996,347:1290-1293.
